<DOC>
	<DOC>NCT02012335</DOC>
	<brief_summary>The purpose of this study is to determine whether combination of ketamine plus electroconvulsive therapy improves depressive symptoms decreasing cognitive side effects.</brief_summary>
	<brief_title>Ketamine Use in Electroconvulsive Therapy</brief_title>
	<detailed_description>This study will compare the clinical response to brief pulse ECT with infusion of ketamine 0.5 mg/kg versus brief pulse electroconvulsive therapy with infusion of placebo (saline) in major depression. We also will compare levels of cognitive impairment among these groups, compare levels of quality of life among these groups, compare levels of BDNF among these groups. We also will study if levels of 25-hydroxyvitamin D are associated with cognitive impairment in subjects undergoing ECT.</detailed_description>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Inclusion criteria Patients with unipolar and bipolar depression from The Psychiatric Unit of Hospital de Clinicas de Porto Alegre (diagnosis will be established by the Structured Clinical Interview for DSMIV Axis I) Exclusion criteria: Patients with dementia History of addiction / abuse of psychoactive drugs Other psychiatric diagnoses Refusal to follow the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>